Abstract
Cytokines are peptide regulatory factors which have been known for more than 40 years. In the past, extensive studies have contributed to a large body of data concerning their structure and their activities. The study of their function included the addition of cytokines to selected cell lines in vitro and the use of inhibitory antibodies and recombinant molecules in vivo. Recently, the production of mice transgenic for cytokine genes, or of mice whose genes encode either cytokines or their receptors, inactivated by homologous recombination (knockout mice), allowed new insight into the function of cytokines in vivo and revealed a whole network of related biological interactions. In contrast to the normal situation, in which the production of cytokines is mostly localized and transient, in the transgenic animals the presence of a transgene, or the complete absence of a targeted gene product, throughout the life of an animal often has consequences different from those that follow the repeated injection of cytokines, which have a short half-life in vivo, or the administration of antibodies, which may not reach every site of cytokine production.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams CWM (1977) Pathology of multiple sclerosis, Br. Med J 33: 15–20
Adkins B, Ghanei A, Hamilton K (1993) Developmental regulation of IL-4, IL-2 and IFN-gamma production by murine peripheral T lymphocytes. J Immunol 151(12): 6617–6626
Anderson DH, Williams DS, Neitz J, Fariss RN, Fliesler SJ (1988) Tunicamycin-induced degeneration in cone photoreceptors. Vis Neurosci 1: 153–158
Anderson JR, Field HJ (1984) An animal model of ocular herpes, keratitis, retinitis and cataract in the mouse. Br J Exp Pathol 65: 283–297
Arai K, Lee F, Miyajima A, Miyatake S, Arai N (1990) Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59: 783–836
Arocker-Mettinger E, Steurer-Georgiew L, Steurer M, Huber-Spitzy V, Hoelzl E, Grabner G, Kuchar A (1992) Circulating ICAM-1 levels in serum of uveitis patients. Curr Eye Res 11 Suppl: 161–166
Atherton SS, Streilein JW (1987) Virus-specific DTH prevents contralateral retinitis following intra-cameral inoculation of HSV-2. Curr Eye Res 6: 133–139
Ayehunie S, Sonnerborg A, Yemane-Berhan T, Zewdie DW, Britton S, Strannegard O (1993) Raised levels of tumor necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected from Ethiopia. Clin Exp Immunol 91: 37–42
Azumi A, Atherton SS (1994) Sparing of the ipsilateral retina after anterior chamber inoculation of HSV-1: Requirement for either CD4+ or CD8+ T cells. Invest Ophthalmol Vis Sci 35: 3251–3259
Batra SK, Brown SM (1990) Herpes simplex virus genes controlling reactivation from latency in rabbit eye model. Indian J Med Res 1991: 252–257
Benacerraf B (1981) Role of MHC gene products in immune regulation. Science 212: 1229–1238
Benveniste EN (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 263: C1–C16
Bernton EW, Bryant HU, Decoster MA, Orenstein JM, Ribas JL, Meltzer MS (1992) No direct neurotoxicity by HIV-1 virions or culture fluids from HIV-infected T cells or monocytes. AIDS Res Hum Retrovir 8: 495–503
Bignami A, Dahl D (1979) The radial glia of Muller in the rat retina and their response to injury. An immunofluorescence study with antibodies to the glial fibrillay acidic protein. Exp Eye Res 28: 63–69
Bignami A, Eng LF, Dahl D, Uyeda CT (1972) Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res 43: 429–435
Birdsall HH (1991) Induction of ICAM-1 on human neural cells and mechanisms of neutrophil-mediated injury. Am J Pathol 139: 1341–1350
Brady ST (1993) Motor neurons and neurofilaments in sickness and in health. Cell 73: 1–3
Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc Natl Acad Sci USA 90: 10061–10065
Campbell IL, Hobbs MV, Kemper P, Oldstone MBA (1994) Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J Immunol 152: 716–723
Capecchi MR (1989) Altering the genome by homologous recombination. Science 244: 1288–1292
Chiang CS, Masliah E, Stalder A, Samimi A, Campbell IL (1994) Gliosis and neurodegeneration as a consequence of the cerebral expression of IL-3 in transgenic mice. Soc Neurosci Abstr 20: 176.14
Côté F, Collard JF, Julien JP (1993) Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell 73: 35–46
Croen KD (1993) Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest 91(6): 2446–2452
Cuthbertson RA, Lang RA, Coghlan JP (1990) Macrophage products IL-1 α, TNF-α and bFGF may mediate multiple cytopathic effects in the developing eyes of GM-CSF transgenic mice. Exp Eye Res 51: 335–344
Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Steward TA (1993) Multiple defects of immune cell function in mice with disrupted interferon-y genes. Science 259: 1739–1742
Dayton ET, Matsumoto-Kobayashi M, Perussia P, Trinchieri G (1985) Role of immune interferon in the monocytic differentiation of human promyelocytic cell lines by leukocyte conditioned medium. Blood 66(3): 583–594
Dix RW, Streilein JW, Cousins S, Atherton SS (1987) Histopathologic characteristics of two forms of experimental herpes simplex virus retinitis. Curr Eye Res 6: 47–52
Egwuagu CE, Sztein J, Chan CC, Reid W, Mahdi R, Nussenblatt RB, Chepelinsky AB (1994) Ectopic expression of gamma interferon in the eyes of transgenic mice induces ocular pathology and MHC class II gene expression. Invest Ophthalmol Vis Sci 35(2): 332–341
Einer SG, Einer VM, Pavilack MA, Todd RF, Mayo-Bond L, Franklin WA, Strieter RM, Kunkel SL, Huber AR (1992) Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells. Lab Invest 66(2): 200–211
Geiger K, Sarvetnick N (1994a) Local production of IFN-γ abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID. J Immunol 153: 5239–5246
Geiger K, Sarvetnick N (1994b) MHC class I expression contributes to the development of cataract in transgenic mice with ectopic expression of IFN-y. In: Nussenblatt RB, Whitcup SM, Caspi RR, Gery I (eds) Advances in ocular immunology. Elsevier, Amsterdam, pp 135-138
Geiger K, Howes E, Gallina M, Huang XJ, Travis GH, Sarvetnick N (1994a) Transgenic mice expressing IFN-y in the retina develop inflammation and photoreceptor loss. Invest Ophthalmol Vis Sci 35(5): 2667–2681
Geiger K, Howes EI, Sarvetnick N (1994b) Ectopic expression of IFN-y in the eye protects transgenic mice from intraocular HSV-1 infections. J Virol 69: 5556–5567
Giulian G, Wendt E, Vaca K, Noonan CA (1993) The envelope glycoprotein of human immunodeficiency virus type 1 stimulated release of neurotoxins from monocytes. Proc Natl Acad Sci USA 90: 2769–2773
Gordon JW (1989) Transgenic animals. Int Rev Cytol 115: 171–227
Gordon YJ (1990) Pathogenesis and latency of herpes simplex virus type 1 (HSV-1): an ophthalmologist’s view of the eye as a model for the study of the virus-host relationship. Adv Exp Med Biol 278: 205–209
Goureau O, Lepoivre M, Courtois Y (1992) Lipopolysaccharide and cytokines induce a macrophage-type of nitric oxide synthase in bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 186(2): 854–859
Guiloff RJ, Tan SV (1992) Central nervous system opportunisitic infections in HIV disease: clinical aspects. Baillieres Clin Neurol 1: 103–154
Hamel CP, Detrick B, Hooks JJ (1990) Evaluation of la expression in rat ocular tissues following inoculation with interferon-gamma. Exp Eye Res 50(2): 173–182
Hamzaoui K, Slim AA, Hamza M, Touraine J (1990) Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behcet’s disease. Clin Exp Immunol 79: 28–34
Hiscott PS, Grierson I, Trombetta CJ, Rahi AHS, Marshall J, McLeod D (1984) Retinal and epiretinal glia. An immunohistochemical study. Br J Ophthalmol 68: 698–707
Hogan RN, Baringer JR, Prusiner SB (1987) Scrapie infection diminishes spines and increases varicosities of dendrites in hamsters: a quantitative Golgi analysis. J Neuropathol Exp Neurol 46: 461–473
Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkemagel RM, Aguet M (1993) Immune response in mice that lack the interferon-y receptor. Science 259: 1742–1745
Hughes CC, Male DK, Lantos PL (1988) Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-gamma, tumor necrosis factor and interleukin-1. Immunology 64: 677–681
Ishida Y, Nishi M, Taguchi O, Inaba K, Hattori M, Minato N, Kawaichi M, Honjo T (1989) Expansion of natural killer cells but not T cells in human interleukin-2/interleukin-2 receptor (Tac) trangenic mice. J Exp Med 170: 1103–1115
Iwakura Y, Asano M, Nishimune Y, Kawade Y (1988) Male sterility of transgenic mice carrying exogenous mouse interferon-beta gene under the control of the metallothionein enhancer-promoter. EMBO J 7: 3757–3762
Janzer RC, Raff MC (1987) Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325: 253–257
John LD, Babcock G, Green D, Freedman M, Sriram S, Ransohoff RM (1992) Transforming growth factor-beta 1 differentially regulates proliferation and MHC class-ll antigen expression in forebrain and brainstem astrocyte primary culture. Brain Res 585(1-2): 229–236
Johnston PV, Roots BI (1976) Neuron-glial relationships. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. North-Holland, Amsterdam, pp 401–421
Klimpel GR, Asuncion M, Fons M, Norton JD, Albrecht T, Klimpel KD, Stein MD (1989) Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts. J Clin Lab Immunol 29: 1–7
Klotzbücher A, Mittnacht S, Kirchner H, Jacobsen H (1990) Different effects of IFNy and IFN α/β on “immediate early” gene expression of HSV-1. Virology 179: 487–491
Kroemer G, De Cid R, De Alboran IM, Gonzalo J-A, Iglesias A, Martinez AC, Gutiérrez-Ramos JC (1991) Immunological self-tolerance: an analysis employing cytokines or cytokine receptors encoded by transgenes or a recombinant vaccinia virus. Immunol Rev 122: 173–204
Lang RA, Metcalf D, Cuthbertson RA, Lyons I, Stanley E, Kelso A, Kannourakis G, Williamson DJ, Klintworth GK, Gonda TJ, Dunn AR (1987) Transgenic mice, expressing a hematopoetic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 51: 675–687
Lem J, Applebury ML, Falk JD, Flannery JG, Simon MI (1991) Tissue-specific and developmental regulation of rod-opsin chimeric genes in transgenic mice. Neuron 6(2): 201–210
Liversidge J, Forrester JV (1992) Antigen processing and presentation in the eye: a review. Curr Eye Res 11 Suppl: 49–58
Lousch RN, Staats H, Oakes JE, Cohen GH, Eisenberg RJ (1991) Prevention of herpes keratitis by monoclonal antibodies specific for discontinuous and continuous epitopes on glycoprotein D. Invest Ophthalmol Vis Sci 32: 2735–2740
Lucchiari MA, Pereira CA (1990) A major role of macrophage activation by interferon-gamma during mouse hepatitis virus type 3 infection. II. Age-dependent resistance. Immunobiology 181(1): 31–39
MacMillan V, Judge D, Wiseman A, Settles D, Swain J, Davis J (1993) Mice expressing a bovince basic fibroblast growth factor transgene in the brain show increased resistance to hypoxemic-ischemic cerebral damage. Stroke 24: 1735–1739
Marcinkiewicz J (1990) Cell-mediated immunity: roll of IL-3 and IL-6 in the regulation of contact sensitivity reaction. Folia Histochem Cytobiol 28: 107–119
Martz E, Gamble SR (1992) How do CTL control virus infections? Evidence for prelytic halt of herpes simplex Viral Immunol 5(1): 81–91
Massa PT, Hirschfeld S, Levi B-Z, Quigley LA, Ozato K, McFarlin DE (1992) Expression of major histocompatibility complex (MHC) class I genes in astrocytes correlates with the presence of nuclear factors that bind to constitutive and inducible enhancers. J Neuroimmunol 41: 35–42
Matthieses MA, Pesson A, Sundquist VA, Wahren B (1988) Neutralization capacity and antibody dependent cell mediated cytotoxicity of separated IgG subclasses 1, 3 and 4 against herpes simplex. J Immunol 72: 211–215
McKendall RR, Woo W (1987) Possible neural basis for age-dependent resistance to neurologic disease from herpes simplex virus. J Neurol Sci 81: 227–237
Meignier B, Norrild B, Roizman B (1983) Colonization of murine ganglia by a superinfecting strain of herpes simplex virus. Infect Immun 41(2): 702–708
Merril JE (1992) Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 14: 1–10
Mitchell WJ, Gressens P, Martin JR, DeSanto R (1994) Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J Gen Virol 75: 1201–1210
Morell P, Norton WT (1980) Myelin. Sci Am 242: 88–118
Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145–173
Mountz JD, Zhou TJL (1990) Production of transgenic mice and application to immunology and autoimmunity. Am J Med Sci 300: 322–329
Neeley SP, Cross AJ, Crow TJ, Johnson JA, Taylor GR (1985) Herpes simplex virus encephalitis. Neuroanatomical and neurochemical selectivity. J Neurol Sci 71: 325–337
Nesburn AB, Dickinson R, Radnoti M, Green MJ (1976) Experimental reactivation of ocular herpes simplex in rabbits. Surv Ophthalmol 21(2): 185–190
Oldstone MBA, Southern PJ (1993) Trafficking of activated cytotoxic T lymphocytes into the central nervous system: use of a transgenic model. J Neuroimmunol 46: 25–32
Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY (1985) Acquired immune deficiency syndrome: Pathogenic mechanisms of ocular disease. Ophthalmology 92(1): 472–484
Perry VH, Gordon S (1988) Macrophages and microglia in the nervous system. Trends Neurosci 11: 273–277
Perry VH, Hume DA, Gordon S (1985) Immunohistochemical localization of macrophages and microglia in adult and developing mouse brain. Neuroscience 15: 313–326
Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239(4840): 586–592
Price RW, Brew BJ, Rosenblum M (1990) The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction. Res Publ Assoc Res Nerv Ment Dis 68: 269–290
Provinciali M, Muxxioli M, Fabris N (1989) Timing of appearance and disappearance of IFN and IL-2 induced natural immunity during ontogenetic development and aging. Exp Gerontol 24(3): 227–236
Raff MC, Mirsky R, Fields KL, Lisak RP, Dorfman SH, Silberberg DH, Gregson NA, Leibowitz S, Xennedy M (1978) Galactocerebroside is a specific cell surface antigenic marker for oligo-dendrocytes in culture. Nature 274: 813–815
Rail GF, Mucke L, Nerenberg M, Oldstone MBA (1994) A transgenic mouse model to assess the interaction of cytotoxic T lymphocytes with virally infected, class I MHC-expressing astrocytes. J Neuroimmunol 52: 61–68
Ramshaw IA, Ruby J, Ramsay A (1992) Cytokine expression by recombinant viruses-a new vaccine strategy. Tibtech 10: 424–426
Ranscht B, Clapshaw PA, Pride J, Noble M, Seifert W (1982) Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA 79: 2709–2713
Rock DL, Fräser NW (1983) Detection of the HSV-1 genome in central nervous system of latently infected mice. Nature 302: 523–525
Rossol-Voth R, Rossol S, Schutt KH, Corridori S, de Cian W, Falke D (1991) In vitro protective effect of tumor necrosis factor alpha against experimental infection with herpes simplex type 1. J Gen Virol 72: 143–147
Satoh T, Nakamura S, Taga T, Matsuda T, Hirano T, Kishimoto T, Kaziro Y (1988) Induction of neuronal differentiation in PC12 cells by B cell-stimulatory factor 2/interleukin-6. Mol Cell Biol 8: 3546–3549
Schlote W (1991) HIV-encephalopathy. Verh Dtsch Ges Pathol 17: 51–60
Schneider-Schaulies J, Kirchhoff F, Archelos J, Schachner M (1991) Down-regulation of myelin-asociated glycoprotein on Schwann cells by interferon-gamma and tumor necrosis factor-alpha affects neurite outgrowth. Neuron 7: 995–1005
Shankar V, Kao M, Hamir AN, Sheng H, Koprowski H, Dietzschold B (1992) Kinetics of virus level and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus. J Virol 66(2): 992–998
Sharer LR (1992) Pathology of HIV-1 infection of the central nervous system: a review. J Neuropathol Exp Neurol 51: 3–11
Sligh JE, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A, Beaudet AL (1993) Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA 90: 8529–8533
Smith KA (1992) lnterleukin-2. Curr Opin Immunol 4: 271–276
Spiezia KV, Dille BJ, Mushahwar IK, Kifle L, Okasinski GF (1990) Prevalence of specific antibodies to herpes simplex virus type 2 as revealed by an enzyme-linked immunoassay and Western blot analysis. Adv Exp Med Biol 278: 231–242
Streilein JW (1993) Immune privilege as the result of local tissue barriers immunosuppressive microenvironments. Curr Opin Immunol 5: 428–432
Suzumura A, Silberberg DH, Lisak RP (1986) The expression of MHC antigens on oligodendrocytes: induction of polymorphic H-2 expression by lymphokines. J Neuroimmunol 71: 179–190
Taverne J (1993) Transgenic mice in the study of cytokine function. Int J Exp Pathol 74: 525–546
Trousdale MD, Steiner I, Spivack JG, Deshmane SL, Brown SM, McLean A, Subak-Sharpe JH, Fraser NW (1991) In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J Virol 65(12): 6989–6993
Van Snick JV (1990) lnterleukin-6: an overview. Annu Rev Immunol 8: 253–278
Vann VR, Atherton SS (1991) Neural spread of herpes simplex virus after anterior chamber inoculation. Invest Ophthalmol Vis Sci 32: 2462–2472
Vazeux R (1990) AIDS encephalopathy and tropism of HIV for brain monocytes/macrophages and microglial cells. Pathobiology 59: 214–218
Vitkovic L, Da Cunha A, Tyor WR (1993) Cytokine expression and pathogenesis in AIDS brain. In: Price PW, Perry SW (eds) HIV, AIDS, and the brain. Raven, New York
Wawrousek EF, Lai JC, Gery I, Chan CC (1994) Progressive inflammatory disease and neova-scularization in the eyes of interleukin-1β transgenic mice. In: Nussenblatt RB, Whitcup SM, Caspi RR, Gery I (eds) Advances in ocular immunology. Elsevier, Amsterdam, pp 143–146
Weinstein DL, Walker DG, Akiyama H, McGeer PL (1990) Herpes simplex virus type I infection of the CNS, induces major histocompatibility complex antigen expression on rat microglia. J Neurosci Res 26: 55–65
Whittum-Hudson JA, Pepose JS (1988) Herpes simplex virus type 1 induces anterior chamber-associated immune deviation (ACAID) in mouse strains resistant to intraocular infection. Curr Eye Res 7(2): 125–130
Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW (1984) Inducible expression of H-2 and la antigens on brain cells. Nature 310: 688–691
Zack DJ, Bennett J, Wang Y, Davenport C, Klaunberg B, Gaerhart J, Nathans J (1991) Unusual topography of bovine rhodopsin promoter-LacZ fusion gene expression in transgenic mouse retinas. Neuron 6(2): 187–199
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Geiger, K., Sarvetnick, N. (1996). The Influence of Cytokines on the Central Nervous System of Transgenic Mice. In: Chisari, F.V., Oldstone, M.B.A. (eds) Transgenic Models of Human Viral and Immunological Disease. Current Topics in Microbiology and Immunology, vol 206. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85208-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-85208-4_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85210-7
Online ISBN: 978-3-642-85208-4
eBook Packages: Springer Book Archive